Top Markets
#1 Cortex Cortex +33.88%
#2 Seeker Seeker +17.50%
#3 Official Trump Official Trump +9.41%
#4 EXOD EXOD +9.04%
#5 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +7.86%
#6 TDCCP TDCCP +5.78%
#7 aelf aelf +5.06%
#8 Fake World Assets Fake World Assets +4.68%
#9 Melania Meme Melania Meme +4.33%
#10 Solstice Solstice +4.12%
Coin of the day
Cortex Cortex
Settings
Language
ENGLISH
Currency
USD
Theme
Damora Therapeutics, Inc. Damora Therapeutics, Inc.

Damora Therapeutics, Inc.

DMRA
Rank in Stocks #6695
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering... Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye, its corporate operations are based in Boston, Massachusetts.
Share Price
$30.90
Last synced: 2026-08-27
Market Cap
$1.90B
Change (1 day)
1.68%
Change (1 year)
859.63%
Country
US
Trade Damora Therapeutics, Inc. (DMRA)

Category

Healthcare
Dividend yield history for Damora Therapeutics, Inc. (DMRA)
Damora Therapeutics, Inc. (stock symbol: DMRA) dividend yield (TTM) as of 2026: 0
Average dividend yield, last 5 years : 0.00%
Dividend yield history for Damora Therapeutics, Inc. (DMRA) from 2026 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
Not enough data for the provided dates.
Dividend yields (TTM) for similar companies or competitors
Company Dividend Yield Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH